2017
DOI: 10.1016/j.jksus.2016.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticles for mosquito control: Challenges and constraints

Abstract: Mosquito control programs are facing important and timely challenges, including the\ud recent outbreaks of novel arbovirus, the development of resistance in several Culicidae species,\ud and the rapid spreading of highly invasive mosquitoes worldwide. Current control tools mainly rely\ud on the employment of (i) synthetic or microbial pesticides, (ii) insecticide-treated bed nets, (iii) adult\ud repellents, (iv) biological control agents against mosquito young instars (mainly fishes, amphibians\ud and copepods… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
50
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 87 publications
(53 citation statements)
references
References 100 publications
1
50
0
2
Order By: Relevance
“…Also, economic issues can limiting the broad commercialization of nano-based formulations (Ventola, 2017;Jones et al, 2019). In comparison to conventional therapies, the production of a nano-based formulations required higher initial investments that will only be worth it from a business perspective if brings good opportunities for the pharmaceutical company, justifying their investment of R&D sector and reduce substantially health care costs (Benelli et al, 2017;Hua et al, 2018). Future research should explore the possibility of (i) determine the mechanism of action of nano-based formulations; (ii) understand the behavior and interaction of nanomaterial in complex biological matrix, such as human body; (iii) evaluate the possible toxicity and residual effects of nanomaterials in both target and non-target organisms; (iv) development of a international legislation; (v) create a standard definition of nanotechnology and nanomaterials, and (vi) standardized methods for establishing the risk-benefit of nanomaterials, in order to create large scale production of nanodevices to fight against of arboviruses as suggested in literature (Parisi et al, 2015;Kah et al, 2018a,b).…”
Section: Gaps Obstacles and Conclusionmentioning
confidence: 99%
See 1 more Smart Citation
“…Also, economic issues can limiting the broad commercialization of nano-based formulations (Ventola, 2017;Jones et al, 2019). In comparison to conventional therapies, the production of a nano-based formulations required higher initial investments that will only be worth it from a business perspective if brings good opportunities for the pharmaceutical company, justifying their investment of R&D sector and reduce substantially health care costs (Benelli et al, 2017;Hua et al, 2018). Future research should explore the possibility of (i) determine the mechanism of action of nano-based formulations; (ii) understand the behavior and interaction of nanomaterial in complex biological matrix, such as human body; (iii) evaluate the possible toxicity and residual effects of nanomaterials in both target and non-target organisms; (iv) development of a international legislation; (v) create a standard definition of nanotechnology and nanomaterials, and (vi) standardized methods for establishing the risk-benefit of nanomaterials, in order to create large scale production of nanodevices to fight against of arboviruses as suggested in literature (Parisi et al, 2015;Kah et al, 2018a,b).…”
Section: Gaps Obstacles and Conclusionmentioning
confidence: 99%
“…In this regard, the importance of nanobiotechnology has been gradually realized as an emerging technology of the future due to exceptional new benefits (Suganya et al, 2017). In the vector control applications, nanoparticles could be applied for: (a) the development of new drugs, with higher activity, decreased toxicity and sustained release; (b) development of new repellent formulations based on natural or synthetic compounds; (c) control of vectors by the use of nanoparticles with repellent, insecticidal or larvicidal activities (Magro et al, 2019); and (d) development of biosensors that can rapidly detect and diagnose the mosquito transmitted viral diseases (Durán et al, 2016;Benelli et al, 2017;Nicolini et al, 2017a). Due to the lack of specific drugs for viral diseases, nanobiotechnology has appeared as an important new breakthrough, which could be potentially used for treatment of patients infected with arboviruses.…”
Section: Introductionmentioning
confidence: 99%
“…Metallic nanoparticles have been effectively used against many species of parasitic larva and adult's insects Benelli et al (81). Green synthesized TiO 2 NPs have also been found to be effective larvicidal agents against various species of parasitic insects as shown in Table 5.…”
Section: Anti-parasitic Activitiesmentioning
confidence: 99%
“…Diseases transmitted by mosquitoes lead to commercial and labor output losses, particularly in countries with tropical and subtropical climates [2]. Mosquitoes represent a huge threat for millions of people worldwide, since they spread various tropical diseases, especially malaria, which is transmitted by female A. gambiae mosquitoes [3].…”
Section: Introductionmentioning
confidence: 99%